PRB1
gene geneOn this page
Also known as PMPMFPMSPRB1MPRB1L
Summary
PRB1 (proline rich protein BstNI subfamily 1, HGNC:9337) is a protein-coding gene on chromosome 12p13.2, encoding Basic salivary proline-rich protein 1 (P04280).
Predicted to be located in extracellular region.
Source: NCBI Gene 5542 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 123 total
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9337 |
| Approved symbol | PRB1 |
| Name | proline rich protein BstNI subfamily 1 |
| Location | 12p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PM, PMF, PMS, PRB1M, PRB1L |
| Ensembl gene | ENSG00000251655 |
| Ensembl biotype | protein_coding |
| OMIM | 180989 |
| Entrez | 5542 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000240636, ENST00000500254, ENST00000545626
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000240636 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002034275 | 11353074 | 11354002 |
| ENSE00002213614 | 11351823 | 11351929 |
| ENSE00002241430 | 11355490 | 11355590 |
| ENSE00003508248 | 11354519 | 11354554 |
Expression profiles
Bgee: expression breadth broad, 56 present calls, max score 94.67.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0185 / max 33.9165, expressed in 1 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 129673 | 3.2896 | 7 |
| 129662 | 0.0185 | 1 |
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.67 | gold quality |
| tonsil | UBERON:0002372 | 65.59 | gold quality |
| bone marrow | UBERON:0002371 | 63.68 | gold quality |
| sural nerve | UBERON:0015488 | 62.64 | gold quality |
| bone marrow cell | CL:0002092 | 62.10 | silver quality |
| putamen | UBERON:0001874 | 59.27 | gold quality |
| caudate nucleus | UBERON:0001873 | 58.95 | gold quality |
| nucleus accumbens | UBERON:0001882 | 56.04 | gold quality |
| colonic epithelium | UBERON:0000397 | 52.69 | gold quality |
| skin of leg | UBERON:0001511 | 49.78 | gold quality |
| zone of skin | UBERON:0000014 | 48.45 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 48.36 | gold quality |
| skin of abdomen | UBERON:0001416 | 46.37 | gold quality |
| Ammon’s horn | UBERON:0001954 | 46.27 | gold quality |
| primary visual cortex | UBERON:0002436 | 46.17 | gold quality |
| right frontal lobe | UBERON:0002810 | 44.41 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 42.63 | gold quality |
| cerebral cortex | UBERON:0000956 | 42.45 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 42.29 | gold quality |
| frontal cortex | UBERON:0001870 | 41.53 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 41.31 | gold quality |
| brain | UBERON:0000955 | 39.85 | gold quality |
| granulocyte | CL:0000094 | 39.26 | gold quality |
| prefrontal cortex | UBERON:0000451 | 39.21 | gold quality |
| liver | UBERON:0002107 | 38.52 | gold quality |
| amygdala | UBERON:0001876 | 37.37 | gold quality |
| temporal lobe | UBERON:0001871 | 37.27 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.07 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.41 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting PRB1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-15B-3P | 97.85 | 66.68 | 974 |
| HSA-MIR-4639-3P | 97.54 | 67.12 | 787 |
| HSA-MIR-4670-3P | 97.37 | 68.35 | 1378 |
| HSA-MIR-6748-3P | 97.20 | 65.66 | 836 |
| HSA-MIR-6759-3P | 96.94 | 68.31 | 823 |
| HSA-MIR-616-3P | 96.82 | 66.99 | 784 |
Literature-anchored findings (GeneRIF, showing 1)
- MP4 and Prb1 in mouse are closely related with the physiology and pathological processes of the ocular surface, and might ontribute to homeostasis of ocular surface or pathogenesis of diseases like dry eye. (PMID:27588265)
Cross-species orthologs
0 orthologs
Paralogs (6): PRR4 (ENSG00000111215), PRB2 (ENSG00000121335), PRH2 (ENSG00000134551), PRB3 (ENSG00000197870), PRB4 (ENSG00000230657), PRH1 (ENSG00000231887)
Protein
Protein identifiers
Basic salivary proline-rich protein 1 — P04280 (reviewed: P04280)
All UniProt accessions (3): A0A0D9SET1, A0A4W8X8U3, G3V1R1
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Post-translational modifications. O-glycosylated. O-glycosylation on Ser-87 is prevalent in head and neck cancer patients. O-Glycosylation on Ser-330 has a 5 times prevalence in head and neck cancers. Proteolytically cleaved at the tripeptide Xaa-Pro-Gln, where Xaa in the P(3) position is mostly lysine. The endoprotease may be of microbial origin. Pyroglutamate formation occurs on terminal Gln residues of cleaved peptides. Besides on the N-terminal of mature PBR1, pyroglutamate formation found on at least Gln-58.
Polymorphism. The number of repeats is polymorphic and varies among different alleles. The sequence shown is that of allele L (long). There are allele M (medium) and allele S (short) which contain 12 and 9 approximate tandem repeats respectively.
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026086 | Pro-rich | Family |
Pfam: PF15240
UniProt features (57 total): repeat 15, sequence conflict 12, compositionally biased region 10, sequence variant 5, chain 4, modified residue 4, glycosylation site 4, region of interest 2, signal peptide 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P04280-F1 | 47.26 | 0.02 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 17, 40, 92, 150
Glycosylation sites (4): 40, 87, 150, 330
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
ENK_UV_RESPONSE_KERATINOCYTE_UP, SHEPARD_BMYB_MORPHOLINO_DN, BROWNE_HCMV_INFECTION_6HR_UP, SA_G1_AND_S_PHASES, YOSHIMURA_MAPK8_TARGETS_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, RAO_BOUND_BY_SALL4_ISOFORM_A, MIR15B_3P, SA_REG_CASCADE_OF_CYCLIN_EXPR, WP_SPINAL_CORD_INJURY, DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS, TRAVAGLINI_LUNG_SEROUS_CELL, WP_PLEURAL_MESOTHELIOMA, GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1354 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRB1 | PRB4 | P02813 | 956 |
| PRB1 | PRH1 | P02810 | 890 |
| PRB1 | C4BPA | P04003 | 819 |
| PRB1 | RB1 | P06400 | 786 |
| PRB1 | STATH | P02808 | 581 |
| PRB1 | SMR3B | P02814 | 513 |
| PRB1 | X6REF7 | X6REF7 | 500 |
| PRB1 | SFTPA2 | P07714 | 497 |
| PRB1 | OPRPN | P85047 | 453 |
| PRB1 | IL6R | P08887 | 406 |
| PRB1 | FURIN | P09958 | 388 |
| PRB1 | PMF1 | Q6P1K2 | 377 |
| PRB1 | A0A087WT04 | A0A087WT04 | 370 |
| PRB1 | PRR4 | Q16378 | 368 |
| PRB1 | SLC29A4 | Q7RTT9 | 351 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GTF2B | NME2P1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (25): UBQLN1 (Two-hybrid), PRB1 (Affinity Capture-MS), PRB1 (Reconstituted Complex), PRB1 (Affinity Capture-MS), PRB1 (Positive Genetic), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid), PRB1 (Two-hybrid)
ESM2 similar proteins: A0A087WUL8, A0A1D9BZF0, B2SU53, F8W0I5, H0YM25, O36421, O46383, P02812, P02849, P02895, P03211, P04280, P04927, P04928, P06916, P08116, P08676, P08726, P09593, P0DPF3, P0DX00, P12027, P13813, P13822, P14708, P16230, P17437, P21850, Q01033, Q01042, Q03400, Q04118, Q1HVF7, Q26005, Q27905, Q3BBV0, Q3KSS4, Q4WW98, Q54G14, Q5MJ10
Diamond homologs: P02810, P02812, P04280, Q04118, Q16378, P10163
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
123 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 112 |
| Likely benign | 7 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
267 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:11353998:ATTTC:A | acceptor_gain | 1.0000 |
| 12:11353999:TTTC:T | acceptor_gain | 1.0000 |
| 12:11354000:TTC:T | acceptor_gain | 1.0000 |
| 12:11354000:TTCC:T | acceptor_loss | 1.0000 |
| 12:11354001:TC:T | acceptor_gain | 1.0000 |
| 12:11354002:CC:C | acceptor_gain | 1.0000 |
| 12:11354003:C:A | acceptor_loss | 1.0000 |
| 12:11354003:C:CC | acceptor_gain | 1.0000 |
| 12:11354003:C:T | acceptor_gain | 1.0000 |
| 12:11354004:T:C | acceptor_loss | 1.0000 |
| 12:11354011:C:CT | acceptor_gain | 1.0000 |
| 12:11354012:A:T | acceptor_gain | 1.0000 |
| 12:11353068:TCATA:T | donor_loss | 0.9900 |
| 12:11353069:CATA:C | donor_loss | 0.9900 |
| 12:11353070:ATAC:A | donor_loss | 0.9900 |
| 12:11353071:TAC:T | donor_loss | 0.9900 |
| 12:11353072:ACC:A | donor_loss | 0.9900 |
| 12:11353073:C:G | donor_loss | 0.9900 |
| 12:11353999:TTTCC:T | acceptor_gain | 0.9900 |
| 12:11354000:TTCCT:T | acceptor_gain | 0.9900 |
| 12:11355486:TTA:T | donor_loss | 0.9900 |
| 12:11355487:TA:T | donor_loss | 0.9900 |
| 12:11355489:C:CA | donor_loss | 0.9900 |
| 12:11351926:CTTC:C | acceptor_gain | 0.9800 |
| 12:11354001:TCCT:T | acceptor_gain | 0.9800 |
| 12:11351928:TCCT:T | acceptor_loss | 0.9700 |
| 12:11351929:CCTG:C | acceptor_loss | 0.9700 |
| 12:11351930:C:A | acceptor_loss | 0.9700 |
| 12:11351931:TGAAA:T | acceptor_loss | 0.9700 |
| 12:11354002:CCTG:C | acceptor_gain | 0.9700 |
AlphaMissense
927 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1001613411 (12:11355159 A>G), RS1001834186 (12:11356720 G>A), RS1001941977 (12:11356950 G>A,C,T), RS1002501604 (12:11351986 G>A,C), RS1003040034 (12:11354792 C>A), RS1004869310 (12:11355292 C>A,T), RS1005307269 (12:11355684 G>A,C,T), RS1005900671 (12:11354180 A>C), RS1005976583 (12:11351622 G>T), RS1006283943 (12:11353176 A>G,T), RS1006705566 (12:11357423 T>C), RS1009044932 (12:11355871 A>G,T), RS1009353147 (12:11356351 G>A), RS1010132510 (12:11356654 T>C), RS1010720794 (12:11354727 G>A)
Disease associations
OMIM: gene MIM:180989 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Propylthiouracil | affects response to substance | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Zinc | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.